X0306 4/A 2021-10-26 2021-10-28 0 0001452965 MINERVA SURGICAL INC UTRS 0001181338 JAFFE ROSS A MD C/O MINERVA SURGICAL, INC. 4255 BURTON DRIVE SANTA CLARA CA 95054 1 0 0 0 Common Stock 2021-10-26 4 C 0 284437 A 284437 I See Footnote Common Stock 2021-10-26 4 C 0 1789 A 1789 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 818269.09 0.00 D Series D Preferred Stock 72374 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 787049.83 0.00 D Series D Preferred Stock 69613 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 775985.84 0.00 D Series D Preferred Stock 68634 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 834568.37 0.00 D Series D Preferred Stock 73816 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5154.72 0.00 D Series D Preferred Stock 455 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 4958.05 0.00 D Series D Preferred Stock 438 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 4888.35 0.00 D Series D Preferred Stock 432 0 I See Footnote Subordinated Secured Convertible Promissory Note 11.306 2021-10-26 4 C 0 5257.39 0.00 D Series D Preferred Stock 464 0 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 72374 0.00 A Common Stock 72374 72374 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 69613 0.00 A Common Stock 69613 141987 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 68634 0.00 A Common Stock 68634 210621 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 73816 0.00 A Common Stock 73816 284437 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 455 0.00 A Common Stock 455 455 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 438 0.00 A Common Stock 438 893 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 432 0.00 A Common Stock 432 1325 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 464 0.00 A Common Stock 464 1789 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 72374 0.00 D Common Stock 72374 212063 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 69613 0.00 D Common Stock 69613 142450 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 68634 0.00 D Common Stock 68634 73816 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 73816 0.00 D Common Stock 73816 0 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 455 0.00 D Common Stock 455 1334 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 438 0.00 D Common Stock 438 896 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 432 0.00 D Common Stock 432 464 I See Footnote Series D Preferred Stock 2021-10-26 4 C 0 464 0.00 D Common Stock 464 0 I See Footnote The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date. The securities are held by Versant Venture Capital IV, L.P. ("Versant IV"). Versant Ventures IV, LLC ("Versant Ventures IV GP") is the general partner of Versant IV. The Reporting Person is a managing director of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. The securities are held by Versant Side Fund IV, L.P. ("Versant Side Fund IV"). Versant Ventures IV GP is the general partner of Versant Side Fund IV. The Reporting Person is a managing director of Versant Ventures IV GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund IV; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein. Represents $818,269.09 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $787,049.83 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $775,985.84 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $834,568.37 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,154.72 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $4,958.05 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $4,888.35 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. Represents $5,257.39 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602. 2/2. Since there are more than 30 rows associated with the applicable transactions and EDGAR will not allow for the entry of more than 30 rows on a single Form 4, this Form 4 is being filed in conjunction with a second Form 4 by the Reporting Person. The two Form 4s filed by the Reporting Person on the date hereof should be read together as on consolidated filing. This amended Form 4 is being filed to correct an inadvertent omission from the Form 4 filed on October 28, 2021 (the "Prior Form 4"), which omitted the shares held by each of Versant Venture Capital IV, L.P. and Versant Side Fund IV, L.P. This amended Form 4 amends and restates in its entirety the transactions reported in the Prior Form 4. Robin Praeger, Attorney-in-fact for Ross A Jaffe MD 2021-12-08